89bio logo
89bio ETNB
report update icon

Quartalsbericht 2025-Q2
hinzugefügt 23.05.2026

89bio EV/EBITDA | ETNB

EV/EBITDA Jährlich 89bio

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-2.41 -4.28 -4.22 -0.943 1.03 0.832 - - - - - - - -

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert Mindestwert Durchschnitt
1.03 -4.28 -1.67

EV/EBITDA anderer Aktien in der Pharmaeinzelhändler

Name EV/EBITDA Preis % 24h Marktkapitalisierung Land
Annexon Annexon
ANNX
-3.14 $ 3.11 -8.94 % $ 482 M usaUSA
Acasti Pharma Acasti Pharma
ACST
1.28 - 4.01 % $ 150 M canadaCanada
Aptose Biosciences Aptose Biosciences
APTO
1.65 K - -45.71 % $ 1.2 M canadaCanada
Galapagos NV Galapagos NV
GLPG
5.67 - - $ 1.83 B belgiumBelgium
Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals
CYCCP
7.42 - -4.36 % $ 27 M usaUSA
Avenue Therapeutics Avenue Therapeutics
ATXI
0.57 - -52.27 % $ 4.45 M usaUSA
Galmed Pharmaceuticals Ltd. Galmed Pharmaceuticals Ltd.
GLMD
-41 $ 4.63 21.05 % $ 20 M israelIsrael
Achieve Life Sciences Achieve Life Sciences
ACHV
552 $ 6.78 0.89 % $ 296 M usaUSA
Leap Therapeutics Leap Therapeutics
LPTX
0.106 - 368.57 % $ 41.9 M usaUSA
Lumos Pharma Lumos Pharma
LUMO
-0.078 - - $ 35.3 M usaUSA
Gamida Cell Ltd. Gamida Cell Ltd.
GMDA
-3.61 - -18.25 % $ 5.04 M israelIsrael
Axcella Health Axcella Health
AXLA
-0.295 - -16.42 % $ 249 M usaUSA
Metacrine Metacrine
MTCR
0.582 - - $ 24.2 M usaUSA
Zealand Pharma A/S Zealand Pharma A/S
ZEAL
-0.823 - 0.52 % $ 821 M danmarkDanmark
Myovant Sciences Ltd. Myovant Sciences Ltd.
MYOV
-3.16 - -0.04 % $ 2.62 B usaUSA
Bellerophon Therapeutics Bellerophon Therapeutics
BLPH
-3.44 - -74.18 % $ 955 K usaUSA
Idera Pharmaceuticals Idera Pharmaceuticals
IDRA
-1.86 - -23.04 % $ 26.6 M usaUSA
Akero Therapeutics Akero Therapeutics
AKRO
-10.5 - - $ 3.67 B usaUSA
Verona Pharma plc Verona Pharma plc
VRNA
-285 - - $ 69.7 B britainBritain
Atreca Atreca
BCEL
17.4 - -11.76 % $ 5.79 M usaUSA
Guardion Health Sciences Guardion Health Sciences
GHSI
0.599 - -0.31 % $ 3.64 M usaUSA
Opiant Pharmaceuticals Opiant Pharmaceuticals
OPNT
19.5 - - $ 109 M usaUSA
Akouos Akouos
AKUS
-1.27 - 0.23 % $ 488 M usaUSA
ImmunoGen ImmunoGen
IMGN
-4.27 - - $ 7.92 B usaUSA
Vascular Biogenics Ltd. Vascular Biogenics Ltd.
VBLT
0.477 - -8.77 % $ 12.4 M israelIsrael
Cidara Therapeutics Cidara Therapeutics
CDTX
-0.0568 - - $ 1.41 B usaUSA
Iterum Therapeutics Iterum Therapeutics
ITRM
-2.81 - - $ 591 K irlandaIrlanda
Virpax Pharmaceuticals Virpax Pharmaceuticals
VRPX
-0.15 - -45.12 % $ 2.85 M usaUSA
Navidea Biopharmaceuticals Navidea Biopharmaceuticals
NAVB
-1.39 - -2.99 % $ 2.47 M usaUSA
Stealth BioTherapeutics Corp Stealth BioTherapeutics Corp
MITO
-10.8 - - $ 23.9 M usaUSA
OncoSec Medical Incorporated OncoSec Medical Incorporated
ONCS
-0.728 - 31.87 % $ 1.61 M usaUSA
BioDelivery Sciences International BioDelivery Sciences International
BDSI
8.87 - -4.8 % $ 255 M usaUSA
Albireo Pharma Albireo Pharma
ALBO
-3.46 - -0.23 % $ 916 M usaUSA
bluebird bio bluebird bio
BLUE
-2.04 - - $ 546 M usaUSA
Landos Biopharma Landos Biopharma
LABP
-0.743 - 0.58 % $ 144 M usaUSA
CASI Pharmaceuticals CASI Pharmaceuticals
CASI
0.542 - - $ 35.4 M usaUSA
ContraFect Corporation ContraFect Corporation
CFRX
-0.383 - -5.16 % $ 5.39 M usaUSA
Sigilon Therapeutics Sigilon Therapeutics
SGTX
-1.08 - - $ 728 M usaUSA
Regulus Therapeutics Regulus Therapeutics
RGLS
0.619 - - $ 155 M usaUSA
NGM Biopharmaceuticals NGM Biopharmaceuticals
NGM
-0.613 - - $ 127 M usaUSA
Aravive Aravive
ARAV
-0.832 - -13.39 % $ 1.45 M usaUSA
Checkmate Pharmaceuticals Checkmate Pharmaceuticals
CMPI
-0.186 - - $ 231 M usaUSA
Crinetics Pharmaceuticals Crinetics Pharmaceuticals
CRNX
-8.07 $ 84.95 0.13 % $ 7.99 B usaUSA
Acer Therapeutics Acer Therapeutics
ACER
-1.56 - 2.71 % $ 14 M usaUSA
Gilead Sciences Gilead Sciences
GILD
16.9 $ 166.01 -0.31 % $ 207 B usaUSA
Assembly Biosciences Assembly Biosciences
ASMB
-25.1 $ 22.14 -1.6 % $ 248 M usaUSA
Dynavax Technologies Corporation Dynavax Technologies Corporation
DVAX
4.01 K - - $ 2.02 B usaUSA
Turning Point Therapeutics Turning Point Therapeutics
TPTX
-8.12 - -0.13 % $ 3.73 B usaUSA
Orgenesis Orgenesis
ORGS
-1.03 - -33.86 % $ 61.2 M usaUSA
TCR2 Therapeutics TCR2 Therapeutics
TCRR
-0.615 - - $ 58.1 M usaUSA